Citation: N. Veys et al., PAIN AT THE INJECTION SITE OF SUBCUTANEOUSLY ADMINISTERED ERYTHROPOIETIN - PHOSPHATE-BUFFERED EPOETIN-ALPHA COMPARED TO CITRATE-BUFFERED EPOETIN-ALPHA AND EPOETIN-BETA, Clinical nephrology, 49(1), 1998, pp. 41-44
Authors:
VANHOLDER R
CAMEZ A
VEYS N
VANLOO A
DHONDT AM
RINGOIR S
Citation: R. Vanholder et al., PHARMACOKINETICS OF RECOMBINANT HIRUDIN IN HEMODIALYZED END-STAGE RENAL-FAILURE PATIENTS, Thrombosis and haemostasis, 77(4), 1997, pp. 650-655
Authors:
LAMEIRE N
VOGELAERS D
VERSCHRAEGEN G
VEYS N
Citation: N. Lameire et al., VANCOMYCIN-RESISTANT ENTEROCOCCI - A THREAT TO THE NEPHROLOGIST ON THE HORIZON - GLYCOPEPTIDE-RESISTANT ENTEROCOCCI AND ICDC-RECOMMENDATIONS FOR A LIMITED USE OF GLYCOPEPTIDES, Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2402-2406
Citation: N. Veys et N. Lameire, EXIT-SITE INFECTION - IS THERE AN ALTERNATIVE TO CATHETER REMOVAL, Nephrology, dialysis, transplantation, 10(12), 1995, pp. 2184-2186
Authors:
VANHOLDER R
BURGELMAN M
VEYS N
DESMET R
VOOGELEERE P
RINGOIR S
Citation: R. Vanholder et al., 2 POOL VERSUS SINGLE POOL MODELS IN THE DETERMINATION OF UREA KINETIC-PARAMETERS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 531-531
Citation: N. Veys et al., INFLUENCE OF ERYTHROPOIETIN ON DIALYZER REUSE, HEPARIN NEED, AND UREAKINETICS IN MAINTENANCE HEMODIALYSIS-PATIENTS, American journal of kidney diseases, 23(1), 1994, pp. 52-59
Authors:
VEYS N
LAMEIRE N
MALERCZYK V
LEHR KH
RINGOIR S
ROSENKRANZ B
Citation: N. Veys et al., SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS RECEIVING HEMODIALYSIS AND IN PATIENTS TREATED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 395-401